** Morgan Stanley says the outlook for European chemicals
remains challenging over weak demand in Q3, and very few players
can expect a rebound in the second half of the year
** MS suspects this has been a muted summer, with "order
books still running light" and few macro factors offering
near-term support"
** Morgan Stanley expects some companies to move in the
lower end of their profit guidance range, even when including
cost savings (like BASF BASFn.DE , Evonik EVKn.DE ), or even
slide lower and face another downgrade as they still wait for
China stimulus
** Across MS coverage, 11 European chemical companies saw
FY23 earnings expectations downgraded, 4 companies guided
towards the lower end of previously set range and 3 companies
reiterating their outlook
** The brokerage believes it is too early to turn optimistic
over the sector before seeing clear "signs of inflection" such
as an uptick in order books, a step-up in Chinese production
activity or a government stimulus
** MS is more confident in specific stocks like Akzo Nobel,
AKZO.AS on compelling margin expansion, and Lanxess LXSG.DE ,
which is seeing an improvement in free cash flow generation and
deleveraging beyond 2023
** It cuts Elkem ELK.OL to "equal weight" from
"overweight," with the near-term silicone weakness presenting
higher than expected downside risk to earnings and free cash
flow
** Shares of European chemicals sector .SX4P fell almost
5% in the last month
(Reporting by Matteo Allievi)
((Matteo.allievi@thomsonreuters.com))